Scleroderma and the upper extremity

1. High-Yield Summary

Systemic sclerosis (scleroderma, SSc) is a chronic, multisystem autoimmune connective tissue disease characterized by progressive microvascular obliteration, widespread immune dysregulation, and excessive extracellular matrix deposition culminating in severe cutaneous and visceral fibrosis. Hand and upper extremity involvement occurs in over 90% of affected patients and represents a primary cause of profound physical disability, chronic pain, and loss of independent daily function:

• Pathophysiological Triad: The disease process is driven by widespread microvascular endothelial cell injury and apoptosis, a profound imbalance between potent vasoconstrictors (upregulated endothelin-1) and vasodilators (downregulated prostacyclin and nitric oxide), and persistent transforming growth factor-beta (TGF-β) mediated differentiation of fibroblasts into contractile myofibroblasts, generating excessive type I and type III collagen deposition.
• Biphasic Hand Manifestation: Upper extremity pathology characteristically initiates with an inflammatory “puffy hand” phase marked by non-pitting edema and digital tenosynovitis, which inexorably transitions over months to years into the fibrotic and indurative phase. This phase manifests as sclerodactyly, tethered skin, distal pulp atrophy, joint contractures (proximal interphalangeal flexion, metacarpophalangeal hyperextension, first web space adduction), soft tissue calcinosis cutis, and terminal tuft acro-osteolysis.
• Peripheral Vasculopathy & Digital Ischemia: Raynaud phenomenon represents the universal initial symptom, occurring in >95% of patients. Vasospasm superimposed on fixed, concentric adventitial and intimal fibrosis causes episodic and chronic digital ischemia. Painful digital pitting ulcers develop in approximately 50% of patients, and critical ischemia precipitates dry gangrene requiring digital amputation in 10% to 15% of severe refractory cohorts.
• Multimodal Nonoperative Escalation: Conservative management forms the foundation of care, comprising strict thermal conservation, complete smoking cessation, specialized hand therapy with gentle active and passive range of motion, and step-wise vasodilator pharmacotherapy: first-line oral dihydropyridine calcium channel blockers (nifedipine), phosphodiesterase-5 (PDE-5) inhibitors (sildenafil, tadalafil), endothelin receptor antagonists (bosentan) for digital ulcer recurrence prevention, and intravenous prostacyclin analogues (iloprost) for acute, limb-threatening digital ischemia.
• Targeted Interventional & Operative Modalities: Surgical and interventional options are reserved for medical refractory disease. Modalities include botulinum toxin A neurovascular injections (chemical sympathectomy), microscopic digital and periarterial sympathectomy (Flatt and Jones adventitial stripping), limited curettage of symptomatic calcinosis cutis, and PIP joint shortening arthrodesis in functional flexion (30°–40°) to relieve tension on taut dorsal skin envelopes and compromised digital arteries.

2. Anatomy

Digital Arterial Architecture & Palmar Arches

The vascular supply of the hand relies on dual input from the radial and ulnar arteries, anastomosing through the deep and superficial palmar arches. The deep palmar arch, derived predominantly from the terminal radial artery, courses deep to the flexor tendons and the adductor pollicis transverse head, giving off palmar metacarpal arteries. The superficial palmar arch, formed primarily by the ulnar artery entering through Guyon’s canal superficial to the transverse carpal ligament, provides the primary source of digital perfusion via the common digital arteries. These common digital arteries travel distally within the intermetacarpal spaces volar to the lumbrical muscles, bifurcating at the level of the web spaces into proper digital arteries. Each proper digital artery runs alongside its corresponding proper digital nerve along the ventrolateral aspect of the digit, lying deep to Grayson’s ligament and volar to Cleland’s ligament.

In systemic sclerosis, this macrovascular and microvascular architecture suffers severe structural compromise. The ulnar artery is occluded in 35% to 50% of patients due to concentric intimal fibroelastosis and microthrombosis, transforming the superficial palmar arch into an incomplete or radial-dependent system. Consequently, the common and proper digital arteries experience critically diminished inflow. Superimposed Raynaud vasospasm further obliterates digital perfusion, transforming marginal collaterals into critically ischemic terminal beds.

Cutaneous Microvasculature & Soft Tissue Envelope

The cutaneous microcirculation of the fingers features specialized nutritive capillary loops oriented perpendicular to the skin surface in dermal papillae, alongside thermoregulatory arteriovenous anastomoses (glomus bodies) densely clustered in the subungual and pulp regions. In scleroderma, this microvascular bed undergoes progressive structural disruption. Dermal capillaries demonstrate endothelial swelling, basal lamina duplication, and extensive capillary dropout, resulting in profound avascular areas. Surviving capillaries dilate into tortuous megacapillaries prone to microhemorrhage and thrombosis.

The overlying soft tissue envelope undergoes profound fibrotic remodeling. Normal loose, pliable subcutaneous areolar tissue is replaced by dense, hypocellular collagen bundles anchoring the dermis directly to underlying osteoligamentous structures. This obliterates normal skin turgor, dorsal transverse flexion creases, and distal pulp padding, creating the tight, waxy, inextensible skin characteristic of sclerodactyly.

Surgical Windows & Internervous Planes

Surgical access in the scleroderma hand requires meticulous selection of anatomical corridors to prevent skin edge necrosis and wound breakdown:

• Carpal Tunnel Decompression: Follows the internervous boundary between the median nerve (pronator teres, flexor carpi radialis, flexor digitorum superficialis) and the ulnar nerve (flexor carpi ulnaris, flexor digitorum profundus to the small and ring digits). The longitudinal incision is placed strictly along the interthenar depression in line with the radial border of the ring digit to preserve the palmar cutaneous branch of the median nerve.
• Digital Exposure & Midlateral Incision: Traditional volar Bruner zig-zag incisions are associated with high rates of skin necrosis due to compromised dermal microcirculation and taut skin tension. The preferred surgical interval is the midlateral digital incision, placed along the coronal line connecting the dorsal extremities of the digital flexion creases. This plane lies dorsal to the neurovascular bundle and Cleland’s ligament, elevating the neurovascular structures volarly in a protective tissue sleeve while avoiding disruption of the attenuated volar dermal blood supply.
• Palmar Digital Sympathectomy Corridor: Exposure of the common digital arteries and superficial palmar arch is achieved via transverse palmar crease incisions or short longitudinal palmar incisions within resting skin lines, avoiding longitudinal crossing of flexion creases and minimizing subcutaneous undermining.

Neurovascular Danger Zones

Surgical dissection in scleroderma is complicated by severe tissue tethering and anatomical distortion:

• Digital Neurovascular Bundles at the PIP Joint: With chronic fixed PIP joint flexion contractures, the proper digital artery and nerve become foreshortened and adherent to contracted pretendinous cords, Grayson’s ligament, and Cleland’s ligament. The neurovascular bundle is drawn volarly and toward the midline directly over the joint apex, making it highly vulnerable to transection during joint exposure or contracture release.
• Subcutaneous Calcinosis Cutis Deposits: Dystrophic calcium hydroxyapatite deposits frequently abut, surround, or directly encase proper digital nerves and arteries within the volar pulp and adjacent to PIP joints. Blind curettage or aggressive blunt dissection without direct microscopic visualization risks tearing fragile, fibrotic arterial walls or severing encased nerve branches.
• Palmar Cutaneous Branch of the Median Nerve (PCBMN): Arises approximately 5 to 6 cm proximal to the distal wrist crease along the radial aspect of the median nerve, traversing distally between the flexor carpi radialis and palmaris longus tendons before crossing superficial to the transverse carpal ligament into the thenar eminence. Radial deviation of incisions at the wrist or aggressive subcutaneous retraction causes neuroma formation and intractable neuropathic pain.
• Recurrent Motor Branch of the Median Nerve: Exits the median nerve near the distal edge of the transverse carpal ligament to innervate the thenar musculature (abductor pollicis brevis, opponens pollicis, superficial head of flexor pollicis brevis). Due to dense palmar fascial fibrosis and thenar adduction contractures, this motor branch may be compressed, tethered, or follow an anomalous transligamentous or subligamentous course, placing it at high risk during carpal tunnel release.

3. Pathogenesis

Microvascular Endothelial Injury & Vasoactive Dysregulation

The primary initiating event in systemic sclerosis is widespread microvascular endothelial cell injury and apoptosis, provoked by anti-endothelial cell antibodies, oxidative stress, and inflammatory cytokines. Endothelial damage triggers chronic activation of the vascular endothelium, resulting in loss of the normal anticoagulant barrier and marked upregulation of cell adhesion molecules (ICAM-1, VCAM-1, and E-selectin). These adhesion molecules recruit circulating mononuclear cells into the perivascular space.

Concurrently, a critical imbalance between endothelial-derived vasoactive mediators develops. Endothelial production of endothelin-1 (ET-1)—a potent vasoconstrictor and smooth muscle mitogen—is markedly upregulated. Simultaneously, endogenous production of prostacyclin (PGI2) and endothelial nitric oxide synthase (eNOS) derived nitric oxide is dramatically diminished. This chemical imbalance creates sustained microvascular vasospasm, chronic vascular hypoperfusion, and downstream platelet activation with luminal microthrombi formation.

Vascular Remodeling & Immune-Mediated Fibrogenesis

Chronic endothelial activation drives profound vascular remodeling. Vascular smooth muscle cells and pericytes proliferate and migrate into the subendothelial space, generating concentric intimal hyperplasia, medial hypertrophy, and dense adventitial collagen deposition. This obliterative vasculopathy progressively narrows the vessel lumen until total mechanical obstruction occurs. This process is distinct from necrotizing systemic vasculitis because it lacks transmural fibrinoid necrosis or leukocytoclasia.

In parallel, the immune cascade amplifies tissue fibrosis. Perivascular infiltrates dominated by activated CD4+ T helper cells (demonstrating a polarized Th2 and Th17 phenotype) and activated macrophages secrete profuse profibrotic cytokines, including transforming growth factor-beta (TGF-β), platelet-derived growth factor (PDGF), interleukin-4 (IL-4), interleukin-6 (IL-6), and connective tissue growth factor (CTGF/CCN2). TGF-β acts as the master transcriptional regulator, stimulating canonical SMAD2/3 signaling and non-canonical pathways to drive resident fibroblasts and perivascular mesenchymal cells into persistently activated alpha-smooth muscle actin (α-SMA) positive myofibroblasts. These myofibroblasts escape physiological apoptosis and constitutively synthesize massive quantities of type I and type III collagen, fibronectin, and proteoglycans.

Tissue Hypoxia, Acro-Osteolysis & Dystrophic Calcinosis

Progressive luminal obliteration and capillary dropout generate chronic, severe tissue hypoxia. Rather than stimulating productive collateral vessel formation, hypoxia in scleroderma impairs vascular endothelial growth factor (VEGF) receptor signaling, producing non-functional, chaotic angiogenesis while aberrantly upregulating hypoxia-inducible factor 1-alpha (HIF-1α) and TGF-β, establishing a self-perpetuating fibrotic vicious cycle.

In the distal digits, chronic severe hypoxia triggers resorption of the terminal phalangeal tufts, termed acro-osteolysis. Hypoperfusion of the periosteal microvasculature compromises osteoblast viability while local inflammatory cytokines (TNF-α, IL-1β) and the receptor activator of nuclear factor-κB ligand (RANKL) axis stimulate osteoclast differentiation and pathological bone resorption. Concurrently, dystrophic calcinosis cutis arises within hypoxic, devitalized subcutaneous tissues and areas of repetitive mechanical shear. Local tissue necrosis and impaired intracellular calcium regulation lead to precipitation of insoluble calcium hydroxyapatite crystals within the dermal and subcutaneous fibrous matrix.

4. Natural History & Epidemiology

Epidemiology & Demographic Distribution

Systemic sclerosis has an estimated annual incidence of 10 to 20 per million individuals and a prevalence of 150 to 300 per million in North America and Western Europe. The disease exhibits a marked female predilection, with a female-to-male ratio ranging from 4:1 to 8:1 during the peak childbearing years, narrowing to approximately 2:1 in postmenopausal age groups. The typical age of onset is between 30 and 50 years, although juvenile and late-onset variants occur.

Subtype Classification & Systemic Manifestations

The disease is categorized into two major clinical subsets based on the anatomical distribution of cutaneous sclerosis:

• Limited Cutaneous Systemic Sclerosis (lcSSc): Represents approximately 60% to 70% of cases. Skin involvement is restricted to the digits and hands (sclerodactyly), face, and neck, remaining distal to the elbows and knees. Historically termed CREST syndrome (Calcinosis, Raynaud phenomenon, Esophageal dysmotility, Sclerodactyly, Telangiectasia), this variant features a prolonged prodrome where Raynaud phenomenon precedes skin changes by years or decades. Long-term risks include isolated precapillary pulmonary arterial hypertension (PAH) and severe late digital ischemia.
• Diffuse Cutaneous Systemic Sclerosis (dcSSc): Accounts for 30% to 40% of cases. Features rapid, progressive skin thickening extending proximal to the elbows and knees and involving the trunk and anterior chest. Raynaud phenomenon typically begins concurrently with or shortly before cutaneous tightening. Patients face a high early risk of life-threatening visceral complications, including fibrosing interstitial lung disease (ILD), scleroderma renal crisis (SRC), and myocardial fibrosis, alongside rapid progression of severe hand contractures.
• Systemic Sclerosis Sine Scleroderma: A rare subtype (<5%) featuring characteristic visceral fibrosis, vascular disease, and specific serologies in the total absence of clinically detectable skin tightening.

Natural History of Upper Extremity Involvement

Upper extremity involvement progresses through three distinct, overlapping clinical phases:

• Edematous (Puffy Hand) Phase: Typically lasts months. Characterized by painless or pruritic non-pitting swelling of the fingers and dorsum of the hands, morning stiffness, and carpal tunnel syndrome secondary to tenosynovial thickening.
• Indurative (Fibrotic) Phase: Develops over 1 to 3 years. The skin becomes waxy, taut, shiny, and bound to deep structures. Transverse skin creases disappear, fingers become tapered, and progressive joint contractures emerge, driven by cutaneous tethering, collateral ligament shortening, and periarticular capsular fibrosis.
• Atrophic (Late) Phase: The skin may gradually soften and thin, but fixed osteoarticular deformities persist. Digital pulp volume is permanently lost, soft tissue calcinosis cutis enlarges, and acro-osteolysis progresses.

Digital ulcers develop in approximately 50% of all SSc patients over their lifetime, with 30% experiencing recurrent or non-healing chronic ulcers. Without aggressive vasodilator therapy and targeted local intervention, critical ischemic progression precipitates dry gangrene, tissue necrosis, and secondary osteomyelitis, necessitating digital amputation in 10% to 15% of high-risk patients.

5. Clinical Presentation

History

Patients with upper extremity scleroderma present with a constellation of vascular, cutaneous, and musculoskeletal complaints:

• Raynaud Phenomenon: The classic historical hallmark, characterized by cold-induced or stress-induced episodic color changes of the digits. The classic triphasic sequence comprises: 1. Pallor (White): Sudden intense vasoconstriction of digital arteries causing ischemic blanching. 2. Cyanosis (Blue): Sluggish capillary flow with accumulation of deoxygenated hemoglobin during prolonged ischemia. 3. Rubor (Red): Reactive hyperemia upon rewarming, accompanied by throbbing pain, paresthesias, and burning sensations.
• Digital Ulceration & Pain: Exquisite, deep, throbbing pain localized to the fingertip pulp or over bony prominences. Patients distinguish two primary ulcer etiologies: ischemic pulp ulcers (arising from terminal microvascular thrombosis and soft tissue necrosis) and mechanical dorsal ulcers (arising over the extensor surface of contracted PIP joints where tight, stretched skin breaks down under minimal friction).
• Functional Decline & Stiffness: Severe morning stiffness exceeding 60 minutes, progressive loss of manual dexterity, inability to form a composite fist, difficulty grasping large objects (due to first web space adduction), and inability to manipulate fine objects such as buttons, keys, or utensils.
• Compressive Neuropathies: Paresthesias, numbness, and nocturnal tingling in the thumb, index, and middle digits indicating carpal tunnel syndrome, frequently occurring during the initial edematous phase or secondarily due to calcinosis within the carpal canal.

Physical Examination

Physical examination must systematically evaluate the skin, joint biomechanics, vascular competence, and peripheral nerve status:

• Cutaneous Inspection: Sclerodactyly with skin tightening distal to the MCP joints; shiny, hyperpigmented or “salt-and-pepper” depigmented skin; loss of dorsal finger hair and sweat glands; complete flattening of transverse skin creases over the PIP and DIP joints. The fingertip pulp appears atrophic, shrunken, and pointed (“pencil-tip” digits), with pitted digital scars (stellate scars) reflecting prior ischemic infarcts. Periungual telangiectasias and dilated nailfold capillary loops are visible under magnification.
• Joint Deformities & Contractures: 1. Proximal Interphalangeal (PIP) Joints: Fixed flexion contractures, often exceeding 45° to 90°, caused by dorsal skin tightening, collateral ligament contracture, and volar capsular adhesions. 2. Metacarpophalangeal (MCP) Joints: Hyperextension or fixed extension contractures resulting from taut dorsal skin pulling the proximal phalanges into extension, frequently accompanied by compensatory intrinsic-minus postures. 3. First Web Space: Severe adduction contracture of the thumb with obliteration of the web space, bringing the thumb into the plane of the palm and destroying palmar abduction and opposition. 4. Distal Interphalangeal (DIP) Joints: Variable flexion or extension deformities, often stabilized by advanced periarticular fibrosis or spontaneous fusion.
• Calcinosis Cutis: Palpable, firm, irregular subcutaneous deposits located over the volar pulps, dorsal PIP joints, extensor surfaces of the forearms, and olecranon. Lesions may be tender to palpation or actively drain thick, chalky, white calcium hydroxyapatite paste through broken skin, posing a chronic risk for secondary bacterial infection.
• Tendon Friction Rubs: Palpable, coarse, leathery crepitus detected along the flexor tendons in the palm or wrist and extensor tendons across the dorsal retinacular compartments during active or passive finger motion. Tendon friction rubs are strongly predictive of the diffuse cutaneous subset, rapid skin disease progression, and early renal or cardiac involvement.
• Vascular Examination: Allen test to assess patency of the radial and ulnar arteries and integrity of the superficial palmar arch. Digital Allen test to evaluate individual proper digital artery patency. Fingertip capillary refill time is routinely prolonged (>3 seconds) or absent in critical digital ischemia.

6. Imaging and Diagnostic Studies

Plain Radiography

Standard radiographic evaluation of the hand and wrist requires posteroanterior (PA), lateral, and oblique projections. Plain radiographs represent the essential first-line imaging modality to identify pathognomonic skeletal and soft tissue changes:

• Acro-Osteolysis: Hallmark osseous manifestation of terminal microvascular insufficiency. Characterized by progressive resorption of the distal phalangeal ungual tufts, beginning as scalloping and cortical thinning of the tuft margin, advancing to triangular “pencil-tip” narrowing, and culminating in partial or complete disappearance of the distal phalanx.
• Calcinosis Cutis: Appears as dense, amorphous, flocculent, or lobulated radiopacities distributed within the subcutaneous tissues. Most commonly concentrated in the fingertip pulps, periarticular regions of the PIP and DIP joints, and over the ulnar border of the forearm.
• Joint Alignment & Erosive Arthropathy: Radiographs document fixed joint subluxations and dislocations, notably PIP flexion contractures, MCP hyperextension, and first carpometacarpal (CMC) subluxation. Joint space narrowing and marginal or central erosions may be present, resembling erosive osteoarthritis or rheumatoid-like arthropathy without extensive periarticular new bone formation.
• Periarticular Osteopenia: Generalized demineralization of the phalanges and metacarpals secondary to chronic disuse, joint immobilization, and severe localized tissue ischemia.

Vascular Evaluation

Objective hemodynamic and microvascular imaging is essential for staging digital ischemia, directing medical escalation, and assessing surgical revascularization candidates:

• Digital Brachial Index (DBI) & Digital Systolic Pressures: Measured using miniature pneumatic digital cuffs placed around the proximal phalanx coupled with photoplethysmography (PPG) or continuous-wave Doppler probes on the distal pulp. A normal DBI is >0.70. A DBI between 0.50 and 0.70 signifies moderate digital arterial occlusive disease; a DBI <0.50 or an absolute digital systolic pressure <40 mmHg represents critical digital ischemia, highly predictive of failure to heal digital ulcers without intervention.
• Pulse Volume Recording (PVR): Evaluates pulsatile blood volume changes in the finger. A normal brisk, steep upstroke with a dicrotic notch is replaced in scleroderma by a flattened, obstructive waveform with lost pulsatility, confirming fixed organic arterial narrowing rather than isolated vasospasm.
• Nailfold Videocapillaroscopy (NVC): High-resolution (200x) optical microscopy of the periungual nailfold capillary bed provides direct visualization of microvascular architecture, differentiating primary Raynaud disease from secondary scleroderma spectrum vasculopathy. Three validated patterns define disease progression: 1. Early Pattern: Well-preserved capillary density, presence of prominent giant capillaries (apical diameter >50 μm), and few localized microhemorrhages. 2. Active Pattern: Frequent giant capillaries, widespread capillary microhemorrhages, moderate loss of capillaries, and mild disorganization. 3. Late Pattern: Severe, extensive capillary dropout with wide avascular desert-like areas, ramified/arborized bushy neoangiogenesis, and complete architectural disorganization. The late NVC pattern correlates strongly with active digital ulceration and visceral vascular disease.
• Duplex Ultrasound (Color & Power Doppler): Noninvasive assessment using high-frequency linear transducers (15–22 MHz) assesses patency, vessel wall thickening, and peak systolic velocities of the radial, ulnar, superficial arch, and proper digital arteries, reliably identifying ulnar artery occlusion and common digital artery stenosis.
• Computed Tomography Angiography (CTA) & Magnetic Resonance Angiography (MRA): Indicated when proximal macrovascular occlusive disease (brachial, radial, or ulnar artery thrombosis) is suspected or when planning microvascular reconstructive procedures, adventitial sympathectomy, or bypass grafting. High-resolution CTA provides detailed mapping from the aortic arch to the digital arteries, excluding proximal thromboembolism and hypothenar hammer syndrome.

Serology & Laboratory Workup

Serological evaluation provides critical prognostic stratification regarding cutaneous subtype, organ risks, and ischemic severity:

• Antinuclear Antibodies (ANA): Positive in >95% of patients with systemic sclerosis by indirect immunofluorescence on HEp-2 cells, exhibiting centromere, speckled, or nucleolar patterns.
• Anti-Centromere Antibodies (ACA / CENP-B): Strongly associated with limited cutaneous systemic sclerosis (lcSSc / CREST), detected in 50% to 60% of limited cases. Strongly correlates with calcinosis cutis, telangiectasias, recurrent digital ulcers, and late-onset pulmonary arterial hypertension; protective against rapid renal crisis and severe pulmonary fibrosis.
• Anti-Topoisomerase I Antibodies (Anti-Scl-70): Strongly associated with diffuse cutaneous systemic sclerosis (dcSSc), detected in 30% to 40% of diffuse cases. Highly predictive of rapidly progressive cutaneous sclerosis, extensive digital ischemia, and severe fibrosing interstitial lung disease.
• Anti-RNA Polymerase III Antibodies: Present in 10% to 20% of dcSSc patients. Strongly associated with rapid, aggressive skin induration, high lifetime risk of scleroderma renal crisis (SRC), and an increased incidence of synchronous internal malignancy within a 3-year window of scleroderma diagnosis.
• Inflammatory Markers & General Labs: Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are typically normal or mildly elevated; marked elevation suggests active tenosynovitis, overlapping inflammatory myopathy, or secondary bacterial osteomyelitis of calcinosis or digital ulcers. Serum creatinine and urinalysis must be routinely monitored for early microalbuminuria and renal involvement.

7. Classification

Classification of systemic sclerosis and its upper extremity manifestations requires stratification by systemic cutaneous distribution (LeRoy and Medsger criteria) and objective staging of digital ischemia to guide therapeutic intervention:

To direct medical and surgical decision-making for digital compromise, the clinical severity of digital ischemia is staged based on perfusion metrics and tissue integrity:

8. Treatment

Medical / Nonoperative

Medical management represents the mandatory first-line approach in all patients, focusing on mitigating vasospasm, promoting microvascular flow, and preventing progressive joint deformity:

• General & Behavioral Measures: Universal implementation of thermal conservation strategies, including wearing multi-layered warm clothing, heated battery-powered gloves, insulated mittens, and hand warmers. Core body warmth is essential, as core cooling triggers reflex sympathetic vasoconstriction. Absolute cessation of all nicotine products is mandatory, as nicotine exerts profound microvascular vasoconstriction lasting several hours per exposure. Avoidance of sympathomimetic agents, including over-the-counter decongestants (pseudoephedrine), amphetamines, and non-selective beta-blockers.
• Calcium Channel Blockers (CCBs): Dihydropyridine CCBs represent the first-line oral pharmacotherapy for uncomplicated Raynaud phenomenon and mild ischemic symptoms. Extended-release nifedipine (titrated from 30 mg to 60–90 mg daily) or amlodipine (5 to 10 mg daily) inhibits L-type voltage-gated calcium channels in vascular smooth muscle, promoting vasodilation. Adverse effects include peripheral pedal edema, flushing, lightheadedness, and potential worsening of gastroesophageal reflux due to lower esophageal sphincter relaxation.
• Phosphodiesterase-5 (PDE-5) Inhibitors: Indicated for patients with inadequate response to CCBs or active digital ulcers. Sildenafil (20 mg three times daily up to 50 mg three times daily) or tadalafil (10 to 20 mg once daily) selectively inhibits cGMP degradation, augmenting nitric oxide-mediated vasodilation. PDE-5 inhibitors significantly reduce the frequency and severity of Raynaud attacks and accelerate the healing of refractory ischemic digital ulcers.
• Endothelin Receptor Antagonists (ERAs): Bosentan (oral dual ET-A and ET-B receptor antagonist; 62.5 mg twice daily for 4 weeks, then maintenance at 125 mg twice daily) is indicated specifically for the prevention of new digital ulcer formation in patients with recurrent, refractory digital ulceration. Regular monthly liver function monitoring is required due to the risk of transaminitis. Bosentan does not consistently accelerate the healing of existing active ulcers, but significantly reduces new ulcer incidence by approximately 30% to 50%.
• Intravenous Prostacyclin Analogues: Iloprost (or intravenous epoprostenol) represents the gold-standard medical therapy for severe, refractory, limb-threatening digital ischemia and non-healing digital ulcers. Administered as continuous intravenous infusions over 6 to 8 hours daily for 3 to 5 consecutive days (titrated from 0.5 to 2.0 ng/kg/min according to tolerance). Iloprost directly stimulates adenylate cyclase in vascular smooth muscle, inhibits platelet aggregation, and exerts anti-inflammatory properties, promoting rapid pain relief and ulcer re-epithelialization.
• Local Wound Care & Topical Agents: Superficial ulcers require non-adherent silicone dressings, hydrogel, or polyurethane foam dressings to sustain a moist wound environment. Aggressive mechanical debridement of dry, stable eschars is strictly contraindicated, as premature removal uncovers poorly perfused tissue and enlarges the ulcer bed. Dry gangrenous tissue should be painted with topical antiseptics (povidone-iodine) and kept dry until demarcation occurs. Bacterial superinfection (most commonly Staphylococcus aureus and Streptococcus species) necessitates culture-guided oral or intravenous antibiotic therapy.
• Hand Therapy & Splinting: Specialized rehabilitation by a certified hand therapist. Daily active, active-assisted, and gentle passive range of motion and tendon gliding exercises prevent rapid joint contracture progression. Thermal warming of hands prior to exercise improves collagen extensibility. Static progressive or dynamic night extension splinting helps combat PIP flexion deformities. First web space C-splints maintain thumb abduction. Aggressive, forceful passive stretching is contraindicated because it tears fragile, ischemic skin and induces acute soft tissue breakdown.

Interventional & Operative Management

When maximal medical optimization fails to arrest digital ischemia, or when severe joint contractures, symptomatic calcinosis cutis, or impending gangrene supervene, surgical and interventional procedures become necessary:

• Botulinum Toxin A (Botox) Neurovascular Injections: 1. Mechanism: Cleaves the synaptosomal-associated protein 25 (SNAP-25), blocking presynaptic acetylcholine release from postganglionic sympathetic vasoconstrictor nerve terminals. Furthermore, botulinum toxin inhibits the release of nociceptive neuropeptides (substance P, calcitonin gene-related peptide [CGRP]), downregulates cold-sensing alpha-2C adrenergic receptors, and induces sustained microvascular vasodilation. 2. Technique: A total of 50 to 100 units of botulinum toxin A is reconstituted in preservative-free normal saline (typically 10 to 20 units/mL). Using a 30-gauge needle, injections are placed into the palm and web spaces directly adjacent to the common and proper digital neurovascular bundles (10 to 20 units per site at the A1 pulley level and web space margins). 3. Outcomes: Provides profound relief of ischemic rest pain within 48 to 72 hours, increases digital temperatures and perfusion, and achieves complete ulcer healing in 75% to 85% of medically refractory ulcers. Clinical efficacy persists for 4 to 6 months and can be safely repeated.
• Digital / Periarterial Sympathectomy (Flatt & Jones Technique): 1. Goals & Indications: Indicated for critical digital ischemia, chronic non-healing ulcers refractory to pharmacotherapy and botox, and severe ischemic rest pain. Relieves reflex sympathetic vasospasm and eliminates the adventitial constrictive band. 2. Operative Technique: Under operating microscope or high-power loupe magnification (3.5x to 4.5x), exposure is gained via a palmar zig-zag incision or separate short longitudinal incisions across resting skin lines. The common digital arteries and proper digital arteries are mobilized over a distance of 2 to 3 cm. Using micro-scissors and micro-forceps, the thickened, fibrotic adventitia containing the postganglionic sympathetic nerve plexus is meticulously stripped circumferentially (360 degrees) off the arterial wall down to the glistening media. Any small thrombosed arterial branch or occluded collateral constricting the main vessel is divided. If an isolated segmental occlusion of a major digital artery is present with an adequate distal runoff bed, microvascular resection and interposition vein grafting (using a volar forearm vein) can be considered, though diffuse downstream microangiopathy often precludes successful microvascular bypass.
• Surgical Debulking & Curettage of Calcinosis Cutis: 1. Indications: Reserved for discrete subcutaneous calcific masses causing recurrent cutaneous ulceration, chronic purulent or chalky drainage, intractable focal pain, or nerve compression (such as median nerve compression in the carpal canal or digital nerve irritation). 2. Technique: Minimal direct longitudinal or elliptical incisions over the prominence. Careful subcapsular curettage and irrigation of paste-like or stone-like calcium deposits. Radical en-bloc excision is avoided because aggressive dissection threatens thin, devitalized overlying skin and risks injury to encased digital neurovascular structures. Wounds may be loosely approximated or packed open to heal by secondary intention.
• Joint Contracture Management: 1. PIP Joint Arthrodesis: The definitive procedure of choice for severe fixed PIP flexion contractures (>50° to 60°) causing functional impairment, recurrent dorsal skin breakdown, or clawing. The joint is exposed via a dorsal approach or midlateral approach. Critical Principle: Skeletal shortening of 3 to 5 mm (resecting the distal condyles of the proximal phalanx) is mandatory. Shortening eliminates excessive tension on the tight, contracted volar digital neurovascular bundles and relieves dorsal skin tension upon joint extension. The joint is fused in a functional position: 30° of flexion for the index and middle fingers, progressing to 35°–40° for the ring and small fingers. Fixation is achieved with crossed K-wires, tension-band wiring, or headless compression screws. 2. MCP Joint Capsulotomy vs. Arthroplasty: Severe MCP joint extension/hyperextension contractures can be addressed with dorsal capsulotomy, extensor tendon lengthening or tenolysis, and collateral ligament recession. Silicone MCP arthroplasty must be approached with extreme caution; the thin, poorly vascularized skin envelope, deficient soft tissue coverage, and propensity for joint contracture recurrence carry high rates of wound dehiscence, deep infection, and silicone implant extrusion. 3. First Web Space Contracture Release: Severe thumb adduction contractures require surgical release of the first dorsal interosseous and adductor pollicis origin from the third metacarpal, dorsal skin z-plasty or transposition flap, and temporary transfixion of the first and second metacarpals with an external K-wire spacer for 4 to 6 weeks.
• Digital Amputation: 1. Principles: Amputation is strictly reserved as an operation of last resort for irreversible, demarcated dry gangrene, wet gangrene with spreading cellulitis, or intractable chronic osteomyelitis. 2. Technique: Complete auto-amputation and clear mummification demarcation should be permitted whenever possible under sterile dry dressing protocols. When surgical completion is required, bone must be shortened conservatively to allow tension-free primary closure or healing by secondary intention, preserving every possible millimeter of viable digital length for pinch and grasp mechanics.

Indications & Contraindications

Clear objective criteria must guide the transition between nonoperative, interventional, and open surgical management:

• Indications for Botulinum Toxin Injections: 1. Active ischemic digital ulcers failing to heal after 8 to 12 weeks of optimized medical therapy. 2. Severe, disabling Raynaud rest pain with DBI <0.70. 3. Rapidly progressive digital ischemia during cold winter months as a bridge or alternative to open surgery.
• Indications for Digital Periarterial Sympathectomy: 1. Non-healing or enlarging digital ulcers refractory to multi-agent medical therapy and botulinum toxin injections. 2. Persistent critical digital ischemia with digital systolic pressure <40 mmHg or DBI <0.50. 3. Severe, intractable ischemic rest pain requiring narcotic analgesics.
• Indications for PIP Arthrodesis: 1. Fixed PIP joint flexion deformity >50°–60° with loss of functional grasp. 2. Recurrent dorsal skin ulceration over the PIP joint condyles. 3. Severe painful joint destruction or erosive instability.
• Absolute Contraindications: 1. Active, uncontrolled local soft tissue infection or ascending cellulitis at the surgical incision site. 2. Unstable acute medical status (e.g., active scleroderma renal crisis or decompensated pulmonary arterial hypertension). 3. Extensive multi-level proximal macrovascular occlusion without identifiable distal collateral landing vessels.
• Relative Contraindications: 1. Active tobacco use or unwillingness to stop smoking (drastically reduces sympathectomy patency and increases ulcer recurrence). 2. Severe, hidebound skin sclerosis with extensive subcutaneous calcinosis where primary wound closure without extreme tension is unattainable. 3. Unrealistic patient expectations regarding recovery of full active digital range of motion.

9. Outcome

Evidence-based outcomes in upper extremity scleroderma demonstrate that targeted interventions provide substantial symptomatic relief, ulcer resolution, and functional stabilization, although the underlying systemic microangiopathy continues to advance over long-term follow-up:

• Digital Periarterial Sympathectomy: Long-term clinical series demonstrate immediate relief of rest pain in 90% to 95% of treated digits. Complete healing of active digital ulcers is achieved in 80% to 92% of cases within 4 to 8 weeks postoperatively. Re-ulceration rates range from 20% to 35% at 3 to 5 years, reflecting progressive distal obliterative microangiopathy; however, secondary amputations are prevented in over 85% of critically ischemic digits undergoing timely sympathectomy.
• Botulinum Toxin A Digital Injections: Systematic reviews and cohort studies show ulcer healing in 75% to 85% of medically refractory ulcers within 6 to 12 weeks. Visual analog scale (VAS) pain scores show significant reductions, decreasing from a baseline average of 7–8/10 to 1–2/10 within 1 to 2 weeks post-injection. Objective digital surface temperatures increase by an average of 1.5°C to 3.0°C, accompanied by improved laser Doppler flowmetry. Therapeutic effects persist for 4 to 6 months, after which repeat injections sustain clinical remission.
• PIP Shortening Arthrodesis: Achieves successful radiographic osseous union in 85% to 92% of joints when rigid internal fixation (tension-band wire or headless compression screw) is maintained. Bone shortening reliably decompresses dorsal skin envelopes, resolving chronic mechanical dorsal ulcers in >90% of digits and preventing ischemic fingertip necrosis by eliminating stretch on volar digital arteries.
• Patient-Reported Outcome Measures (PROMs): Functional recovery is objectively quantified using validated upper extremity instruments: 1. Cochin Hand Function Scale (CHFS): Demonstrates clinically meaningful improvements (mean score reduction >10–15 points) following multimodal management, reflecting enhanced capacity for eating, dressing, and hygiene tasks. 2. QuickDASH (Disabilities of the Arm, Shoulder and Hand): Shows sustained score reductions following sympathectomy and chemical denervation, correlating with diminished pain and improved upper limb functional tolerance. 3. Scleroderma Health Assessment Questionnaire (SHAQ): Captures meaningful decreases in visual analog scales for digital ulcers and vascular pain, directly correlating with enhanced health-related quality of life.

10. Complications

Surgical interventions in scleroderma patients carry an intrinsically elevated complication profile due to impaired dermal microcirculation, dense tissue fibrosis, and systemic vasculopathy:

11. Pearls and Pitfalls

Achieving successful outcomes in the surgical and clinical management of the scleroderma hand demands adherence to nuanced surgical pearls and avoidance of treacherous technical pitfalls:

• Mandatory Skeletal Shortening in Arthrodesis: When performing PIP joint arthrodesis for severe fixed flexion contractures, never attempt to straighten the digit by soft tissue release alone. The proper digital arteries are chronically shortened and tethered. Forcible extension without bone resection stretches the fibrotic digital vessels beyond their compliance limit, inducing irreversible arterial spasm and digital gangrene. Always resect 3 to 5 mm of bone from the distal proximal phalanx to relax the volar neurovascular bundle and decompress the dorsal skin envelope.
• Incision Placement Dorsal to the Neurovascular Bundle: Use midlateral digital incisions placed strictly along the coronal line connecting the dorsal ends of the digital flexion creases. This keeps the incision dorsal to Cleland’s ligament and the digital neurovascular bundle, maintaining the entire volar skin and neurovascular structures as a single vascularized composite flap. Avoid mid-volar or Bruner zig-zag incisions whenever possible.
• The “Wait and Demarcate” Rule for Dry Gangrene: In the presence of mummified, dry digital gangrene without active wet infection or ascending cellulitis, resist the temptation to perform early formal surgical amputation. Keep the eschar dry and painted with topical povidone-iodine. Allow complete auto-amputation and epithelial demarcation to occur. Surgical incisions through under-perfused, demarcating tissues frequently fail to heal, necessitating more proximal amputation.
• Screen for Ulnar Artery Occlusion Prior to Wrist Surgery: The ulnar artery is occluded in up to 50% of systemic sclerosis patients. Always perform an objective Doppler examination or Allen test prior to any surgical procedure or arterial line placement at the wrist. Sacrificing or cannulating the radial artery in a patient with an occult ulnar artery thrombosis will precipitate catastrophic acute hand ischemia and global digital necrosis.
• Avoid Silicone PIP/MCP Arthroplasty in Hidebound Hands: Although silicone spacer arthroplasty is standard in rheumatoid arthritis, its use in scleroderma is fraught with disaster. Inelastic, poorly vascularized skin envelopes cannot accommodate the implant, leading to wound dehiscence, foreign-body sinus formation, deep sepsis, and implant extrusion. Arthrodesis in functional position remains the standard of care for destroyed or contracted PIP joints.
• Gentle Calcinosis Debulking Without En-Bloc Resection: Never attempt radical, en-bloc excision of diffuse calcinosis cutis. Aggressive dissection tears attenuated overlying skin and severs intimately adherent proper digital nerves and vessels. Utilize small, focused incisions to express toothpaste-like deposits or curette discrete symptomatic calcific stones, leaving the deeper adherent bed undisturbed.

12. Controversy

Several clinical and operative controversies remain active subjects of investigation in the management of upper extremity scleroderma:

• Botulinum Toxin A vs. Open Digital Periarterial Sympathectomy: Both modalities seek to eliminate sympathetic vasoconstriction. Botulinum toxin A offers a minimally invasive “chemical sympathectomy” that is easily administered in the outpatient clinic setting, avoids surgical incisions in compromised ischemic skin, and carries minimal procedural morbidity. However, its therapeutic effects are temporary, necessitating repeat injections every 4 to 6 months. Conversely, open digital periarterial sympathectomy (Flatt and Jones technique) provides permanent mechanical denervation and allows simultaneous release of constrictive adventitial bands, but carries surgical risks of wound necrosis, infection, and arterial injury. Current consensus favors botulinum toxin A as the primary interventional step, reserving open sympathectomy for refractory ulcers or critical digital ischemia that fails to respond to chemical denervation.
• Arthroplasty vs. Arthrodesis for Severe PIP Joint Deformity: Motion-preserving silicone or surface-replacement arthroplasty remains highly controversial in scleroderma. Proponents argue that preserving even 20° to 30° of motion enhances functional hand scores. However, the overwhelming consensus among hand surgeons favors PIP joint arthrodesis. The high rates of skin necrosis, wound dehiscence, late contracture recurrence, and silicone implant extrusion in scleroderma make arthroplasty hazardous. Arthrodesis with bone shortening reliably stabilizes the joint, eliminates pain, relieves vascular stretch, and permits primary skin healing.
• Autologous Fat Grafting (Lipofilling) and Regenerative Cell Therapies: Subcutaneous transplantation of purified autologous fat into the hands and digits has emerged as a promising regenerative therapy. Adipose tissue is a rich source of adipose-derived stem cells (ADSCs) and pericytes, which secrete potent pro-angiogenic factors (VEGF, basic fibroblast growth factor) and anti-fibrotic cytokines. Preliminary clinical trials demonstrate improvements in skin softness, digital ulcer healing, cold tolerance, and hand function. Nonetheless, questions remain regarding long-term graft survival, standardized processing protocols, optimal injection volumes, and the risk of localized microvascular compression from overfilling ischemic tissues. Controlled randomized trials are ongoing to define its definitive role.

13. Evidence-Based Synthesis

Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.

14. References

• Del Galdo F, Lescoat A, Conaghan PG et al. EULAR recommendations for the treatment of systemic sclerosis: 2023 update. Ann Rheum Dis. 2025. doi:10.1136/ard-2024-226430 [Level IV: Clinical Case Series / Cohort Study]
• Zhu C, Peri K, Silotch C et al. Botulinum Toxin for Refractory Digital Ischemia and Ulcers in Systemic Sclerosis: A Systematic Review and Meta-Analysis. JAMA Dermatol. 2026. doi:10.1001/jamadermatol.2025.4929 [Level I: Systematic Review / Meta-Analysis]
• Hachulla E, Hatron PY, Carpentier P et al. Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study. Ann Rheum Dis. 2016. doi:10.1136/annrheumdis-2014-207001 [Level I: Randomized Controlled Trial]
• Flatt AE. Digital artery sympathectomy. J Hand Surg Am. 1980. doi:10.1016/s0363-5023(80)80104-3 [Level IV: Clinical Case Series / Cohort Study]
• Jones NF, Imbriglia JE, Steen VD et al. Surgery for scleroderma of the hand. J Hand Surg Am. 1987. doi:10.1016/s0363-5023(87)80012-6 [Level IV: Clinical Case Series / Cohort Study]

15. Master Class Pro-Tip

When undertaking surgical intervention in the scleroderma hand—whether performing PIP joint arthrodesis, calcinosis debulking, or web space release—the paramount surgical principle is that skeletal shortening is your most powerful ally against soft tissue ischemia and skin necrosis. In the setting of severe sclerodactyly and PIP flexion contractures, the digital vessels and nerves are chronically shortened, tethered, and operating at the threshold of critical ischemia. Attempting full passive extension without skeletal decompression will stretch the fibrotic digital arteries beyond their compliance limit, precipitating acute spasm and irreversible digital thrombosis. Resecting 3 to 5 millimeters of bone from the distal condyles of the proximal phalanx during PIP arthrodesis completely decompresses the volar neurovascular bundle and provides instantaneous laxity to the attenuated dorsal skin envelope. Furthermore, always utilize midlateral incisions placed strictly dorsal to the neurovascular axis, avoid any subcutaneous flap undermining, and never perform digital Allen testing or arterial clamping without intraoperative papaverine or lidocaine irrigation on hand to counter catastrophic microvascular vasospasm.

Master Class Surgical Pearl: Microvascular Preservation in Scleroderma Hand Reconstruction